ArticleCurrent cancer drug targets2025

TBOPP, a DOCK1 Inhibitor, Potentiates Cisplatin Efficacy in Breast Cancer by Regulating Twist-mediated EMT.

Xin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.